Pepper crop under climate change: Grafting as an environmental friendly strategy In: RaoCSShankerAKShankerC, editors
Status: Ongoing ID: NCT06944522 Brief Summary: Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess the efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD)
Your body becomes unable to produce energy when your B12 levels decrease, which leads to persistent fatigue despite getting enough rest
Intracellular reactions promoted by bis(histidine) miniproteins stapled using palladium(II) complexes
"Great product, easy to use, no harsh taste in my opinion and great benefits." Annesa W
To view or add a comment, sign in CT-388 Enters Phase III in 2025: Dual GLP-1/GIP Candidate Targets USD 150 Billion Obesity Market with 18.8% Weight Loss in 24 Weeks, analyses DelveInsight: CT-388 Sales Market Basel, Switzerland Swiss pharmaceutical leader Roche, through its subsidiary Genentech, is accelerating development of its investigational obesity and metabolic therapy CT-388, positioning the candidate as a potential next-generation competitor in the rapidly expanding global obesity and Continue reading #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech To view or add a comment, sign in - Download PDF Brochure: GLP-1 analogue therapies are transforming metabolic disease management from type 2 diabetes to obesity and cardiometabolic risk reduction
